Medicines Company (MDCO), a global pharmaceutical company, announced fourth-quarter results for 2012. Net income attributable to The Medicines Company was $20.7 million, or $0.38 per share, up from $19.6 million, or $0.36 per share in the same quarter last year.
Further, non-GAAP net income for the fourth quarter of 2012 was $42.9 million, or $0.78 per share. Meanwhile, net revenue increased by 20.6 percent to $159.5 million, from $132.2 million in the year-ago quarter.
Analysts polled by Thomson Reuters expected the company to report a profit of $0.21 per share on revenues of $136.46 million for the quarter. Analysts' estimates typically exclude special items.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.